Cost-effectiveness analysis of health tapestry, a complex primary care program for older adults: a post-hoc analysis

被引:0
|
作者
Tarride, J. E. [1 ,2 ]
Blackhouse, G. [1 ]
Lamarche, L. [3 ,4 ]
Forsyth, P. [3 ]
Oliver, D. [3 ]
Carr, T. [3 ]
Howard, M. [3 ]
Thabane, L. [1 ,5 ]
Datta, J. [3 ]
Dolovich, L. [3 ,6 ]
Clark, R. [3 ]
Price, D. [3 ]
Mangin, D. [3 ]
机构
[1] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[2] St Josephs Healthcare Hamilton, Programs Assessment Technol Hlth, Hamilton, ON, Canada
[3] McMaster Univ, Dept Family Med, Hamilton, ON, Canada
[4] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada
[5] St Josephs Healthcare Hamilton, Biostat Unit, Hamilton, ON, Canada
[6] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
来源
BMC PRIMARY CARE | 2024年 / 25卷 / 01期
关键词
Cost-Effectiveness; Health TAPESTRY; Volunteers; Family Health Team; Elder Care; INTERVENTIONS; ADJUSTMENT; DIFFERENCE; POLICY;
D O I
10.1186/s12875-024-02475-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundWe initially reported on the cost-effectiveness of a 6-month randomized controlled implementation trial which evaluated Health TAPESTRY, a primary care program for older adults, at the McMaster Family Health Team (FHT) site and 5 other FHT sites in Ontario, Canada. While there were no statistically significant between-group differences in outcomes at month 6 post randomization, positive outcomes were observed at the McMaster FHT site, which recruited 40% (204/512) of the participants. The objective of this post-hoc study was to determine the cost-effectiveness of Health TAPESTRY based on data from the McMaster FHT site.MethodsCosts included the cost to implement Health TAPESTRY at McMaster as well as healthcare resource consumed, which were costed using publicly available sources. Health-related-quality-of-life was evaluated with the EQ-5L-5L at baseline and at month 6 post randomization. Quality-adjusted-life-years (QALYs) were calculated under an-area-under the curve approach. Unadjusted and adjusted regression analyses (two independent regression analyses on costs and QALYs, seemingly unrelated regression [SUR], net benefit regression) as well as difference-in-difference and propensity score matching (PSM) methods, were used to deal with the non-randomized nature of the trial. Sampling uncertainty inherent to the trial data was estimated using non-parametric bootstrapping. The return on investment (ROI) associated with Health TAPESTRY was calculated. All costs were reported in 2021 Canadian dollars.ResultsWith an intervention cost of $293/patient, Health TAPESTRY was the preferred strategy in the unadjusted and adjusted analyses. The results of our bootstrap analyses indicated that Health TAPESTRY was cost-effective compared to usual care at commonly accepted WTP thresholds. For example, if decision makers were willing to pay $50,000 per QALY gained, the probability of Health TAPESTRY to be cost effective compared to usual care varied from 0.72 (unadjusted analysis) to 0.96 (SUR) when using a WTP of $50,000/QALY gained. The DID and ROI analyses indicated that Health Tapestry generated a positive ROI.ConclusionHealth TAPESTRY was the preferred strategy when implemented at the McMaster FHT. We caution care in interpreting the results because of the post-hoc nature of the analyses and limited sample size based on one site.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Cost-Effectiveness Analysis and Health Policy
    Torgerson, David J.
    ECONOMIC, MEDICAL/SCIENTIFIC AND REGULATORY ASPECTS OF CLINICAL NUTRITION PRACTICE: WHAT IMPACTS WHAT?, 2009, 12 : 95 - 104
  • [42] Cost-effectiveness analysis in health policy
    Graham, JD
    VALUE IN HEALTH, 2003, 6 (04) : 417 - 419
  • [43] COSTS OF HEALTH-CARE - BENEFIT-COST AND COST-EFFECTIVENESS ANALYSIS
    HANSON, I
    HEALTH SERVICES RESEARCH, 1977, 12 (01) : 62 - 67
  • [44] HEALTH-CARE COST-BENEFIT AND COST-EFFECTIVENESS ANALYSIS - AN OVERVIEW
    YIN, DP
    FORMAN, HP
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1995, 6 (03) : 311 - 320
  • [45] COST-EFFECTIVENESS AND BUDGET IMPACT OF ONASEMNOGENE ABEPARVOVEC FOR SPINAL MUSCULAR ATROPHY TYPE 1: POST-HOC ANALYSIS OF A MODEL DEVELOPED BY ICER
    Dabbous, O.
    Dean, R.
    Arjunji, R.
    Sproule, D. M.
    Feltner, D. E.
    Malone, D. C.
    VALUE IN HEALTH, 2019, 22 : S850 - S850
  • [46] AFLIBERCEPT IN COMBINATION WITH FOLFIRI IN PATIENTS WITH METASTATIC COLORECTAL CANCER: COST-EFFECTIVENESS BASED ON VELOUR BEST EFFICACY SUBGROUP POST-HOC ANALYSIS
    Echave, M.
    Oyaguez, I
    Lamas, M. J.
    Rubio, M.
    Subira, R.
    VALUE IN HEALTH, 2015, 18 (07) : A454 - A454
  • [47] Cost-effectiveness analysis of psychotherapy in treatment of essential hypertension in primary care
    Kalmatayeva, Zhanna
    Zholamanova, Ainur
    ARCHIVES OF PSYCHIATRY AND PSYCHOTHERAPY, 2014, 16 (04): : 57 - 63
  • [48] Cost-Effectiveness of a Care Transitions Program in a Multimorbid Older Adult Cohort
    Hanson, Gregory J.
    Borah, Bijan J.
    Moriarty, James P.
    Ransom, Jeanine E.
    Naessens, James M.
    Takahashi, Paul Y.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 (02) : 297 - 301
  • [49] Roadside safety analysis program: A cost-effectiveness analysis procedure
    Texas A&M Univ, College Station, United States
    Transp Res Rec, 1647 (67-74):
  • [50] Roadside safety analysis program - A cost-effectiveness analysis procedure
    Mak, KK
    Sicking, DL
    Zimmerman, K
    GENERAL DESIGN AND ROADSIDE SAFETY FEATURES, 1998, (1647): : 67 - 74